UM

Browse/Search Results:  1-9 of 9 Help

Filters    
Selected(0)Clear Items/Page:    Sort:
Electroconvulsive therapy and its relationships with clinical characteristics and quality of life in Chinese psychiatric patients Journal article
Psychiatry Research, 2016,Volume: 246,Page: 246-249
Authors:  An F.-R.;  Zhang L.;  Zhang Q.-E.;  Ungvari G.S.;  Ng C.H.;  Chiu H.F.K.;  Wu P.-P.;  Jin X.;  Li L.;  Lok G.K.I.;  Xiang Y.-T.
Favorite  |  View/Download:3/0  |  Submit date:2018/12/18
Aggression  Antipsychotic Medication  Electroconvulsive Therapy  Physical Restraint  Quality Of Life  
Gender differences in attitudes towards antipsychotic medications in patients with schizophrenia Journal article
Psychiatry Research, 2016,Volume: 245,Page: 276-281
Authors:  Zhou J.;  Xiang Y.-T.;  Li Q.;  Zhu X.;  Li W.;  Ungvari G.S.;  Ng C.H.;  Ongur D.;  Wang X.
Favorite  |  View/Download:7/0  |  Submit date:2018/12/18
Antipsychotics  Attitude  Gender  Schizophrenia  
Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials Journal article
Acta Psychiatrica Scandinavica, 2016,Volume: 134,Issue: 5,Page: 385-398
Authors:  Zheng W.;  Xiang Y.-T.;  Xiang Y.-Q.;  Li X.-B.;  Ungvari G.S.;  Chiu H.F.K.;  Correll C.U.
Favorite  |  View/Download:5/0  |  Submit date:2018/12/18
Antipsychotic  Meta-analysis  Metabolic Abnormalities  Topiramate  Weight Gain  
Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis Journal article
Human Psychopharmacology, 2016,Page: 286-295
Authors:  Zheng W.;  Xiang Y.-Q.;  Li X.-B.;  Ungvari G.S.;  Chiu H.F.K.;  Sun F.;  D'Arcy C.;  Meng X.;  Xiang Y.-T.
Favorite  |  View/Download:3/0  |  Submit date:2018/12/18
Antipsychotic  Cognitive Function  Huperzine a  Meta-analysis  Schizophrenic-spectrum Disorders  Systematic Review  
Electroconvulsive therapy added to non-clozapine antipsychotic medication for treatment resistant schizophrenia: Meta-analysis of randomized controlled trials Journal article
PLoS ONE, 2016,Volume: 11,Issue: 6
Authors:  Zheng W.;  Cao X.-L.;  Ungvari G.S.;  Xiang Y.-Q.;  Guo T.;  Liu Z.-R.;  Wang Y.-Y.;  Forester B.P.;  Seiner S.J.;  Xiang Y.-T.
Favorite  |  View/Download:4/0  |  Submit date:2018/12/18
Extract of Ginkgo biloba for Tardive Dyskinesia: Meta-analysis of Randomized Controlled Trials Journal article
Pharmacopsychiatry, 2016,Volume: 49,Issue: 3,Page: 107-111
Authors:  Zheng W.;  Xiang Y.-Q.;  Ng C.H.;  Ungvari G.S.;  Chiu H.F.K.;  Xiang Y.-T.
Favorite  |  View/Download:7/0  |  Submit date:2018/12/18
Antipsychotic  Ginkgo Biloba  Meta-analysis  Tardive Dyskinesia  
Trends in the access to and the use of antipsychotic medications and psychotropic co-treatments in Asian patients with schizophrenia Journal article
Epidemiology and Psychiatric Sciences, 2016,Volume: 25,Issue: 1,Page: 9-17
Authors:  Y.-T. Xiang;  G. S. Ungvari;  C. U. Correll;  H. F. K. Chiu;  N. Shinfuku
Favorite  |  View/Download:5/0  |  Submit date:2019/01/07
Asia, , Psychotropic  Schizophrenia  Prescription Patterns  Medications  
Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials Journal article
EXPERT OPINION ON DRUG SAFETY, 2016,Volume: 15,Issue: 5,Page: 591-612
Authors:  Galling, B;  Roldan, A;  Rietschel, L;  Hagi, K;  Walyzada, F;  Zheng, W;  Cao, XL;  Xiang, YT;  Kane, JM;  Correll, CU
Favorite  |  View/Download:3/0  |  Submit date:2019/01/07
Monotherapy  Metaanalysis  Antipsychotics  Augmentation  Combination  Polypharmacy  Cotreatment  Adverse Effects  Tolerability  Safety  Schizophrenia  
Antipsychotic polypharmacy and quality of life in patients with schizophrenia treated in primary care in China Journal article
International Journal of Clinical Pharmacology and Therapeutics, 2016,Volume: 54,Issue: 1,Page: 36-42
Authors:  Hou C.-L.;  Ma X.-R.;  Zang Y.;  Jia F.-J.;  Lin Y.-Q.;  Chiu H.F.K.;  Ungvari G.S.;  Ng C.H.;  Zhong B.-L.;  Cao X.-L.;  Li Y.;  Cai M.-Y.;  Xiang Y.-T.
Favorite  |  View/Download:4/0  |  Submit date:2018/12/18
Antipsychotic Polypharmacy  China  Community-dwelling  Schizophrenia